UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing*First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and ...
Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) is pleased to announce its 2026 budget with capital projects driving profitable growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback